Instrument Inactif

Autres langues Strongbridge Biopharma

Actions

SBBP

IE00BYZ5XL97

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Strongbridge Biopharma plc(NasdaqGS:SBBP) dropped from S&P Global BMI Index	07/10/21
Strongbridge Biopharma plc(NasdaqGS:SBBP) dropped from S&P TMI Index	07/10/21
STRONGBRIDGE BIOPHARMA PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	05/10/21
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.	05/10/21
Strongbridge Biopharma : plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.	05/10/21
Strongbridge Biopharma plc(NasdaqGS:SBBP) dropped from NASDAQ Composite Index	05/10/21
Xeris Pharmaceuticals, Inc. completed the acquisition of Strongbridge Biopharma plc from HealthCap VI L.P., a fund managed by Odlander, Fredrikson & Co. AB, Caxton Alternative Management LP, and others.	05/10/21
Strongbridge Biopharma : Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.	23/09/21
Xeris Pharmaceuticals : Shareholders Approve Pending Strongbridge Biopharma Acquisition	15/09/21
Strongbridge Biopharma : Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc (Form 8-K)	08/09/21
STRONGBRIDGE BIOPHARMA PLC : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	08/09/21
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.	08/09/21
Strongbridge Biopharma : Says Glass Lewis Recommends Shareholders Vote in Favor of Proposed Deal with Xeris	31/08/21
Xeris Pharmaceuticals : Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris	31/08/21
Strongbridge Biopharma : Certain Litigation Relating to the Transaction (Form 8-K)	30/08/21
STRONGBRIDGE BIOPHARMA PLC : Other Events (form 8-K)	30/08/21
Xeris Pharmaceuticals : ISS Recommends Xeris, Strongbridge Shareholders Vote in Favor of Proposed Deal	30/08/21
Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris	30/08/21
STRONGBRIDGE BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	05/08/21
Strongbridge Biopharma: Q2 Earnings Snapshot	05/08/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Strongbridge Biopharma

Actions

SBBP

IE00BYZ5XL97

Autres langues

Filtres